Mitochondrial microRNA detection using a sequentially activatable allosteric DNA biosensor for in vivo molecular visualization of tumors and tumor drug resistance
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Jingzhe Zang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengz…. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, Mitochondria, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of strategies that enable in situ detection of mitochondrial microRNA (miRNA) remains a significant challenge, as miRNA is widely distributed across various cellular compartments. Therefore, by utilizing the mitochondria-specific localization of cytochrome c (cyt c) as the targeting moiety, a sequentially activatable allosteric DNA biosensor (C-M-tFNA) was developed for the in situ detection of mitochondrial miRNA. In the first configurational change of C-M-tFNA, the interaction between cyt c aptamer-hairpin 1 (apt-HP1) of C-M-tFNA and cyt c triggers a conformational transition in apt-HP1 to HP1, thereby exposing the apurinic/apyrimidinic site (AP site) for cleavage by mitochondrial apurinic/apyrimidinic endonuclease 1 (APE1) and releasing a single-strand cyclic DNA (cyclic sequence). In the second configurational change of C-M-tFNA, the cyclic sequence can hybridize with the green loop on hairpin 2 (HP2) of C-M-tFNA in a circular manner, resulting in a second cleavage by APE1. Finally, in the third configurational change of C-M-tFNA, miRNA can specifically hybridize with the red loop of HP2, inducing a third cleavage mediated by APE1. This process effectively separates the fluorophore from the quencher in a circular manner, leading to the generation of fluorescence signal. Experimental results demonstrate that C-M-tFNA enables highly specific and sensitive in vivo imaging of mitochondrial miRNA. In particular, C-M-tFNA is capable of monitoring drug resistance in neuroblastoma in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
- Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
- Henan Institute for Drug and Medical Device Inspection, Zhengzhou, 450018, China.
- Surgical Oncology, Beijing Children's Hospital, 100045, Beijing, China. Electronic address: qinhong999999@163.com.
- Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: xuy1218@…
- Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhangwan…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zang, J., Wang, T., Zhang, F., Zhang, M., Chen, M., Liu, K., Zhang, X., Qin, H., Xu, Y., & Zhang, W. (2026). Mitochondrial microRNA detection using a sequentially activatable allosteric DNA biosensor for in vivo molecular visualization of tumors and tumor drug resistance. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118046
Vancouver
Zang J, Wang T, Zhang F, Zhang M, Chen M, Liu K, et al. Mitochondrial microRNA detection using a sequentially activatable allosteric DNA biosensor for in vivo molecular visualization of tumors and tumor drug resistance. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118046
BibTeX
@article{Zang2026,
author = {Zang, Jingzhe and Wang, Tingting and Zhang, Fei and Zhang, Mengxin and Chen, Mengmeng and Liu, Kangbo and Zhang, Xianwei and Qin, Hong and Xu, Ying and Zhang, Wancun},
title = {Mitochondrial microRNA detection using a sequentially activatable allosteric DNA biosensor for in vivo molecular visualization of tumors and tumor drug resistance},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118046}
}
EUVIMED